PLA2R1 and nephrotic syndrome: Since anti-PLA2R antibodies, which are present in the serum of about 70% of patients, have a specificity for IMN of almost 100% and their titers correlate with the clinical status [1, 15], if the patient has the typical manifestations of nephrotic syndrome, along with positive antibodies, histological confirmation of the diagnosis is no longer needed.